SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (890)10/10/1998 11:01:00 PM
From: Anthony Wong  Read Replies (2) | Respond to of 1722
 
Merck, AHP [& LLY] Among Drug Stocks Picked by Schroer, Barron's Says

Bloomberg News
October 10, 1998, 4:52 p.m. ET

New York, Oct. 10 (Bloomberg) -- Merck & Co., American Home
Products Corp. and Eli Lilly & Co. are among drugmakers Invesco
Funds Group Inc. portfolio manager John Schroer expects to profit
even in a global recession, Barron's reported. The fund manager
likes the stocks because the companies are developing new drugs
and don't do a lot business in less-stable emerging markets.
McKesson Corp., IMS Health Inc., AmeriSource Health Corp.,
Medtronic Inc. and Sofamor Danek Group Inc. are other stocks
Schroer is buying, the paper said.

Schroer manages the $1.2 billion Invesco Strategic Health
Sciences and $500 million Invesco Global Health Sciences funds.

--Andrew Brooks in the Princeton newsroom (609) 279-4066/gfh